The article discusses the potential of microbiome testing to personalize health and wellness treatments. The global microbiome market is expected to reach over $11 billion by 2027, with a CAGR of 7.2%. Microbiome testing is already being used to customize treatments for type 2 diabetes and GI disorders, and studies are underway for sleep disorders, obesity, depression, and autism spectrum disorder. Current services in the market offer a combination of diagnostics and treatment, including DNA testing, questionnaires, blood tests, consultations, customized apps, food as medicine, supplements, and lifestyle changes.